| PRD_002375 | Name: | cyclic trypsin inhibitor | Formula: | C69 H109 N21 O18 | Definition date: | 2020-07-01 | Last modified: | 2020-07-02 |
|
| PRD_002127 | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H54 N7 O11 P | Definition date: | 2014-12-03 | Last modified: | 2020-06-27 |
|
| PRD_002270 | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | Formula: | C28 H44 N8 O5 | Definition date: | 2017-06-28 | Last modified: | 2020-06-21 |
|
| PRD_002393 | Name: | UAW247 | Formula: | C24 H27 N3 O5 | Definition date: | 2020-06-17 | Last modified: | 2020-06-17 |
|
| PRD_002347 | Name: | ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H32 N4 O4 | Definition date: | 2020-06-03 | Last modified: | 2020-06-03 |
|
| PRD_002349 | Name: | ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H25 F N4 O4 | Definition date: | 2020-06-03 | Last modified: | 2020-06-03 |
|
| PRD_002385 | Name: | Papain-like protease peptide inhibitor VIR250 | Formula: | C23 H32 N6 O6 S | Definition date: | 2020-05-20 | Last modified: | 2020-05-20 |
|
| PRD_002382 | Name: | boceprevir (bound form) | Formula: | C27 H47 N5 O5 | Definition date: | 2020-05-06 | Last modified: | 2020-05-06 |
|
| PRD_001136 | Name: | SUGAR (6-MER) | Formula: | C57 H82 O26 | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | Definition date: | 2013-07-26 | Last modified: | 2020-04-04 |
|
| PRD_002326 | Name: | Phosphinic inhibitor DG014 | Formula: | C62 H91 N9 O18 P | Definition date: | 2019-12-18 | Last modified: | 2019-12-18 |
|
| PRD_002357 | Name: | SHV-WFP-SER-PRO-YCP-ALA-MP8 Acyldepsipeptide | Formula: | C39 H54 F2 N6 O8 | Definition date: | 2019-11-06 | Last modified: | 2019-11-06 |
|
| PRD_002359 | Name: | OO1-WFP-SER-PRO-YCP-ALA-MP8 ureadepsipeptide | Formula: | C40 H49 F2 N7 O8 | Definition date: | 2019-11-06 | Last modified: | 2019-11-06 |
|
| PRD_002368 | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-10-02 | Last modified: | 2019-10-02 |
|
| PRD_002333 | Name: | Pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002334 | Name: | Linear tetrapeptide related to pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002335 | Name: | Linear precursor of pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_001037 | Name: | N~2~-[(2R,5S)-5-({(2S,3S)-2-[(N-acetyl-L-threonyl)amino]-3-methylpent-4-enoyl}amino)-2-butyl-4,4-dihydroxynonanoyl]-L-glutaminyl-L-argininamide | Formula: | C36 H68 N10 O10 | Definition date: | 2012-12-12 | Last modified: | 2019-07-25 |
|
| PRD_002355 | Name: | Microcin C | Formula: | C38 H63 N17 O17 P S | Definition date: | 2019-07-10 | Last modified: | 2019-07-10 |
|
| PRD_002306 | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | Formula: | C54 H77 N9 O12 | Definition date: | 2019-06-04 | Last modified: | 2019-06-04 |
|
| PRD_002311 | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | Formula: | C57 H96 N10 O12 | Definition date: | 2019-05-29 | Last modified: | 2019-05-29 |
|
| PRD_002312 | Name: | (GZJ)VDINNN(CY3) Cyclic peptide inhibitor | Formula: | C36 H58 N12 O14 S | Definition date: | 2019-04-17 | Last modified: | 2019-04-17 |
|
| PRD_002313 | Name: | WDINNN(BAL) Cyclic peptide inhibitor | Formula: | C36 H49 N11 O12 | Definition date: | 2019-04-17 | Last modified: | 2019-04-17 |
|
| PRD_002319 | Name: | (6D6)PPKRIA(NH2), DC100-1 | Formula: | C48 H84 N18 O11 | Definition date: | 2019-04-03 | Last modified: | 2019-04-03 |
|
| PRD_002316 | Name: | Apollo peptide | Formula: | C46 H68 N8 O7 | Definition date: | 2019-02-13 | Last modified: | 2019-02-13 |
|
| PRD_002284 | Formula: | C37 H57 N11 O11 | Definition date: | 2018-11-07 | Last modified: | 2018-11-07 |
|